What's new

What's new

Organisation chart: Human Medicines

Organisation chart: Human Medicines

26 February 2024

Human medicines European public assessment report (EPAR): Zyprexa, olanzapine, Date of authorisation: 27/09/1996, Revision: 43, Status: Authorised

Human medicines European public assessment report (EPAR): Zyprexa, olanzapine, Date of authorisation: 27/09/1996, Revision: 43, Status: Authorised

26 February 2024

Human medicines European public assessment report (EPAR): Sugammadex Piramal, sugammadex, Date of authorisation: 23/06/2023, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Sugammadex Piramal, sugammadex, Date of authorisation: 23/06/2023, Revision: 1, Status: Authorised

26 February 2024

Human medicines European public assessment report (EPAR): Axura, memantine, Date of authorisation: 17/05/2002, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Axura, memantine, Date of authorisation: 17/05/2002, Revision: 28, Status: Authorised

26 February 2024

Human medicines European public assessment report (EPAR): Memantine Merz, memantine hydrochloride, Date of authorisation: 22/11/2012, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Memantine Merz, memantine hydrochloride, Date of authorisation: 22/11/2012, Revision: 8, Status: Authorised

26 February 2024

Nitrosamine impurities

Nitrosamine impurities

26 February 2024

Appendix 1: Acceptable intakes established for N-nitrosamines

Appendix 1: Acceptable intakes established for N-nitrosamines

26 February 2024

Industry Standing Group meetings

Industry Standing Group meetings

26 February 2024

Eighth Industry Standing Group (ISG) meeting, European Medicines Agency, Amsterdam, the Netherlands, 25 March 2024

Eighth Industry Standing Group (ISG) meeting, European Medicines Agency, Amsterdam, the Netherlands, 25 March 2024

26 February 2024

Clinical Trials Information System (CTIS): Walk-in clinic - March 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 12 March 2024, 16:00 (CET) to 12 March 2024, 17:00 (CET)

Clinical Trials Information System (CTIS): Walk-in clinic - March 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 12 March 2024, 16:00 (CET) to 12 March 2024, 17:00 (CET)

26 February 2024